专利号:US-6277489-B1 优先权日:1998-12-04 标题:Support for high performance affinity chromatography and other uses 发明人:ABBOTT NICHOLAS; STROEVE PIETER; DUBROVSKY TIMOTHY B; HOU ZHIZHONG 权利人:UNIV CALIFORNIA 摘要:Multilayered particulate materials are formed by coating a particulate substrate with a metal and adsorbing an organic layer comprising a recognition moiety onto the metal film. The recognition moiety interacts with an analyte of interest allowing for its detection, purification, etc. Suitable recognition moieties can be selected from a range of species including, small molecules, polymers and biomolecules and the like. The novel particulate materials of the invention can be utilized in an array of methods including, ion-exchange, ion-selective ion-exchange, assays, affinity dialysis, size exclusion dialysis, as supports in solid phase synthesis, combinatorial synthesis and screening of compound libraries and the like.
专利号:RU-2139886-C1 优先权日:1992-02-05 标 题 :Photoconsolidated derivative of glycoseaminoglycan, cross- -linked derivative of glycoseaminoglycan and methods of their synthesis, composition for medicinal use, method of prevention of cellular and tissue adhesion
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
专利号:CN-118930508-A 优先权日:2024-07-24 标题:Synthesis process of flavone methylphenidate hydrochloride
专利号:CN-101208345-B 优先权日:2005-05-25 标 题 :(S) -N-methylnaltrexone, method of synthesis and pharmaceutical use thereof
1: Nazir J, Berling M, McCrea C, Fatoye F, Bowditch S, Hakimi Z, Wagg A. Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK. Pharmacoecon Open. 2017 Mar;1(1):25-36. doi: 10.1007/s41669-017-0011-x. 2: Chapple CR, Nazir J, Hakimi Z, Bowditch S, Fatoye F, Guelfucci F, Khemiri A, Siddiqui E, Wagg A. Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice. Eur Urol. 2017 Sep;72(3):389-399. doi: 10.1016/j.eururo.2017.01.037. Epub 2017 Feb 11. Chinese. Available from http://www.ncbi.nlm.nih.gov/books/NBK315844/ doi: 10.1111/luts.12063. Epub 2014 Jun 3. doi: 10.1097/IJG.0000000000000270. Review. doi: 10.4103/2249-4863.152266. 9: Arcaniolo D, Conquy S, Tarcan T. Flavoxate: present and future. Eur Rev Med Pharmacol Sci. 2015;19(5):719-31. Review. doi: 10.1007/s00192-014-2585-5. Epub 2014 Dec 6. Review. doi: 10.1016/j.saa.2014.06.058. Epub 2014 Jun 20. doi: 10.5414/CP202113. doi: 10.1016/j.juro.2014.04.092. Epub 2014 Apr 30. doi: 10.1016/j.ijpharm.2013.12.013. Epub 2013 Dec 22. doi: 10.1159/000339600. Epub 2012 Jul 5. Review. doi: 10.1111/j.1464-410X.2012.11023.x. Epub 2012 Mar 12.
合成参考文献
参考文献:10.1021/np50001a002 摘要:Edwards JM, Raffauf RF, Le Quesne PW. Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. J Nat Prod. 1979 Jan;42(1):85–91. doi: 10.1021/np50001a002.